A Comparison of Continuous Moderate Training and Reduced High Intensity Interval Training in Obese Young Adults

July 28, 2020 updated by: Yasemin Çırak, Istinye University

A Comparison of Reduced HIIT and Moderate Intensity Continuous Exercise in Obese Young Adults

Exercise is a key component of obesity management. Obese subjects cannot attend or sustain exercise program because of increased general fatigue, dyspnea and muscle fatigue. And they feel more exertion when comparing with normal weight subjects. Reduced-exertion high-intensity interval training (REHIT) is a alternative method to continuous exercise programs. The investigators aimed comparing metabolic effects of REHIT and continuous exercise in young adults, in this study.

Study Overview

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey
        • Istınye University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 20 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Between the ages of 18-22,
  • BMI ≥ 30,
  • Female gender,

Exclusion Criteria:

  • Smoking history,
  • Having any metabolic disease except obesity,

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Continuous Exercise
At %60 of maximal heart rate, 30-60 minutes exercise
At %50 of maximum heart rate, 30-60 minutes aerobic exercise
Experimental: REHIT Exercise
At %100 of heart rate 15 seconds, after this period 15 sec recovery period for all step

-Start with warm-up period --> %50 of maximum work rate, 3 minutes

One Exercise Cycle consists of:

  • 15 seconds exercise period: %100 of maximum work rate
  • 15 seconds recovery period: %50 of maximum work rate

Total Duration: 10 minutes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Aerobic Capacity
Time Frame: 1 year
Maximum Oxygen Uptake
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total Exercise Duration
Time Frame: 1 year
Exercise Test Duration
1 year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body Fat Percentage
Time Frame: 1 year
Total Body Fat Percentage
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Nurgul Durustkan Elbasi, PhD, Istinye University
  • Study Chair: Yunus Emre Tutuneken, PT, Istinye University
  • Principal Investigator: Yasemin Cirak, Ass Prof, Istınye U
  • Study Chair: Duygu Korkem, PhD, University of Health science
  • Study Chair: Beyza Karaduz, MsC, Hacettepe University
  • Study Chair: Ebru Calik Kutukcu, PhD, Hacettepe University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2018

Primary Completion (Actual)

April 1, 2019

Study Completion (Actual)

August 1, 2019

Study Registration Dates

First Submitted

December 20, 2019

First Submitted That Met QC Criteria

December 23, 2019

First Posted (Actual)

December 24, 2019

Study Record Updates

Last Update Posted (Actual)

July 30, 2020

Last Update Submitted That Met QC Criteria

July 28, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 0004

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Continuous Aerobic Exercise

3
Subscribe